The purpose of this study is to evaluate safety and effectiveness of the peripheral mechanical stimulation of the feet on gait variables, clinical status, risk of falls, BDNF levels, immunological profile and brain functional connectivity changes in patients with Parkinson's disease.
Patients will be submitted to 8 sessions of peripheral mechanical stimulation of the feet or sham stimulation along 4 weeks. Evaluations will be performed before and after the first session, after the forth and the eighth session.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
28
Universidade Federal de Ciências da Saúde de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
Kinetic and kinematic gait analysis
Evaluated by means of the 3-D motion analysis system (BTS SMART DX 400).
Time frame: 4 weeks of treatment
Risk of falls
Evaluated by means of the Timed Up \& Go Test (TUG).
Time frame: 4 weeks of treatment
Motor impairment
Evaluated by means of the Unified Parkinson Disease Rating Scale (UPDRS III).
Time frame: 4 weeks of treatment
Level of depression
Evaluated by means of the Beck Depression Inventory (BDI).
Time frame: 4 weeks of treatment
Symptoms of Parkinson's disease progress
Evaluated by means of the Hoehn and Yahr scale.
Time frame: 4 weeks of treatment
Serum levels of BDNF
Analyzed in blood sampling.
Time frame: 4 weeks of treatment
Sensorio-motor connectivity
Functional magnetic resonance imaging.
Time frame: 4 weeks of treatment
Lymphocyte Proliferation Assessment
Analyzed in blood sampling.
Time frame: 4 weeks of treatment
Cytokine and Cortisol Assessment
Analyzed in blood sampling.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 4 weeks of treatment